This literature review discusses gender variations in the epidemiology, symptoms, pharmacology, and treatment of heart failure, noting that approximately 50% of US heart failure patients are women.
This review highlights the critical need for providers to understand gender variations in the recognition, diagnosis, and management of heart failure.
Heart failure (HF) numbers continue to grow in the United States and approximately 50% of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.
Eisenberg et al. (Thu,) conducted a review in Heart failure. This literature review discusses gender variations in the epidemiology, symptoms, pharmacology, and treatment of heart failure, noting that approximately 50% of US heart failure patients are women.